John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) — Hackensack, New Jersey

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Neoplasms, Metastatic Solid Tumors, Advanced Solid Tumors.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001)?

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) conducted?

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) has 2 clinical trials on record, with 2 currently active. Their work covers Breast Neoplasms, Metastatic Solid Tumors, Advanced Solid Tumors.

Is John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) accredited by Crixeo Health?

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.